Chemical Structure : INNO-220
CAS No.: 3032577-24-2
Catalog No.: PC-24767Not For Human Use, Lab Use Only.
INNO-220 is a highly selective and potent, CRBN-dependent, orally bioavailable degrader of CK1α without affecting IKZF1/3, impairs cell viability and selectively degraded CK1α in lymphoma cells.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 5 mg | $128 | In stock | |
| 10 mg | $198 | In stock | |
| 25 mg | $348 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
INNO-220 is a highly selective and potent, CRBN-dependent, orally bioavailable degrader of CK1α without affecting IKZF1/3, impairs cell viability and selectively degraded CK1α in lymphoma cells.
INNO-220 inhibits cells harboring wild-type p53 and exhibiting constitutive NF-κB signaling.
INNO-220 inhibits IL-2 expression by disrupting the CBM complex and inhibiting NF-κB activity.
INNO-220 suppresses NF-κB signaling and activates p53 pathway, leading to complete inhibition of lymphoma tumor growth in vivo.
INNO-220 disrupts the assembly and function of the CARD11/BCL10/MALT1 complex, thereby inhibiting NF-κB signaling in stimulated T cells and lymphoma cells that harbor an activating mutation in CARD11.
| M.Wt | 400.44 | |
| Formula | C23H20N4O3 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
3-(5-(1-Methyl-5-phenyl-1H-pyrazol-4-yl)-1-oxoisoindolin-2-yl)piperidine-2,6-dione |
|
1. Feng S, et al. Leukemia. 2025 May 27. doi: 10.1038/s41375-025-02647-x.
2. Patent WO2024054832 A1.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright